Fever and sleep cycle impairment after streptococcal mucopeptide administration

  • Kadlecová O
  • Mašková K
  • Rašková H
 et al. 
  • 4


    Mendeley users who have this article in their library.
  • 9


    Citations of this article.


Mucopeptide, isolated from the cell wall of streptococcus, when injected into rats induces a dose-dependent hyperthermia. Simultaneously a profound disturbance of deep sleep occurs, which appears to be indirectly related to the magnitude of the fever. A monoamine oxidase inhibitor (pargyline) induces a hypothermia in control animals and reverses the fever caused by mucopeptide. Under the influence of pargyline the EEG patterns are changed to that of wakefulness, an effect lasting several hours. At the height of fever, two hr after mucopeptide administration, the turnover rate of hypothalmic 5-hydroxytryptamine is doubled. © 1972.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • O. Kadlecová

  • K. Mašková

  • H. Rašková

  • J. Rotta

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free